LCN2 and myocardial infarction: The report of Karetnikova showed that patients with increased serum NGAL concentrations after 12 days of STEMI had a higher incidence of adverse outcomes such as recurrent myocardial infarction, early post-infarction angina, an acute cerebrovascular event, or death [179].